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Patch-clampThe Ca2+- and oxidative stress-induced mitochondrial permeability transition (MPT) plays an important role
in phenomena ranging from tissue damage upon infarction to muscle wasting in some forms of dystrophy.
The process is due to the activation of a large pore in the inner mitochondrial membrane. Anti-oxidants are
considered a preventive and remedial tool, and mitochondria-targeted redox-active compounds have been
developed. Plant polyphenols are generally considered as anti-oxidants, and thus candidates to the role of
mitochondria-protecting agents. In patch-clamp experiments, easily oxidizable polyphenols induced closure
of the MPT channel. In swelling experiments with suspensions of mitochondria, high (20–50 μM)
concentrations of quercetin, the most efﬁcient inhibitor, promoted instead the onset of the MPT. Chelators
of Fe2+/3+ and Cu+/2+ ions counteracted this effect. Fluorescent indicators of superoxide production
conﬁrmed that quercetin potentiates O2
U− generation by isolated mitochondria and cultured cells. Since this
was not affected by chelating Fe and Cu ions, the MPT-inducing effect can be ascribed to a “secondary”,
metal ion-catalyzed production of ROS. These results are a direct demonstration of the ambivalent redox
character of polyphenols. Their mode of action in vivo cannot be taken for granted, but needs to be
experimentally veriﬁed.© 2009 Elsevier B.V. All rights reserved.1. IntroductionIn mitochondria part of the electrons transported by the
respiratory chain is delivered to oxygen in a process generating
superoxide anion, O2
U
ˉ, and hence H2O2 and reactive oxy and peroxy
radicals ([1] and Refs. therein). While this fraction may be as high as
2–3% in vitro, chronic production of reactive oxygen species (ROS) by
mitochondria in vivo is probably much lower, difﬁcult to estimate and
variable [1]. Nonetheless, its relevance and potential impact are clearly
demonstrated, among much other evidence, by the phenotype of
transgenic mice or cells depleted of or sovraexpressing Mn-SOD [2,3].
Production of ROS by mitochondria is relevant under pathological
circumstances, including cancer and ischemias. Besides being a factor
in carcinogenesis [4] mitochondrial ROS have been linked to
metastatic aggressiveness and angiogenesis in the tumoral mass
([5]; but see [6]). These effects are mediated by the activation of
enzymes such as metalloproteases [7] and transcription factors, mostscience, c/o Department of
, Italy. Tel.: +39 0498276054;
ll rights reserved.notably HIF [8–10]. The intermediacy of ROS in ischemia/reperfusion
(I/R) damage is also well established [1,11,12]. The downstream
effector in this case is, to a considerable extent, the mitochondrial
permeability transition (MPT) [13–16].
The latter phenomenon (reviews: [17–21]) is at the focus of this
paper. Brieﬂy stated, it consists in the opening of an unspeciﬁc
permeation pathway capable of admitting solutes up to 1.5 kDa, the
mitochondrial permeability transition pore (MPTP), in the inner
mitochondrial membrane (IMM). This causes depolarization, uncou-
pling, loss of metabolites and respiration factors such as NADH from the
mitochondrial matrix, ATP depletion, and, if prolonged, leads to necrotic
cell death [14,15]. In studies with isolatedmitochondria theMPT is most
often studied by following its propagation in the population of
suspended organelles by monitoring light scattering. This is possible
because opening of the MPTP induces colloidosmotic swelling. This
method is not well suited to provide information on pore dynamics:
swelling of a single mitochondrion takes place in the time range of 1 s
[22] and once the mitochondrion has swollen, it does not report on the
state of the MPTP. This latter type of information can instead be
obtained by patch-clamping the membrane of mitoplasts. This
approach has allowed a detailed characterization of a high-conductance
pore whose pharmacology matches that of the MPTP [17,23,24].
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Ca2+ is a key effector: in vitro the MPT is difﬁcult to induce unless at
least μM levels of this ion are present in themitochondrial suspension.
Activation by ROS has long been known and indeed it is considered by
some to be an essential feature of the MPT [25–27]. Enhanced ROS
production by Ca2+-treated mitochondria has been observed (e.g.
[28]). Believed to be caused by Ca2+-induced alterations of membrane
lipid–protein interactions, it is a possible mechanism for the
transduction of Ca2+ binding into MPT opening [25,26,28–31]. The
role of thiols in permeability transition onset has been carefully
characterized by Bernardi's group [32–35]. At least two classes of
dithiol sites can be recognized, differing in terms of accessibility to
reagents and to mitochondrial pools of glutathione and pyridine
nucleotides. Another mechanistic model, not necessarily alternative,
envisions an important role of cardiolipin: its conversion to CL
hydroperoxide might favour the formation of the MPTP by IMM
carriers [36], and the detachment of cytochrome c, which can thus
take part in apoptosis [37,38].
The MPT is not only a target for cell-, organ- and life-saving efforts
(e.g. [20,39–42]); it can also represent a tool for the elimination of
unwanted, i.e., cancerous, cells. Its induction by redox stress is one of
the strategies considered in the emerging ﬁeld of mitochondrial
medicine [43,44]. Cancer cells live under intrinsic redox stress and
may thus be more vulnerable than normal ones [45].
Manipulation of the redox state of mitochondria to either inhibit or
enhanceMPToccurrence thus appears to be aworthwhile approach to
the prevention and/or treatment of major pathologies. Since cells
maintain mM levels of “redox buffers” (e.g. glutathione) this
perspective implies that a way is found to obtain sufﬁcient
concentrations of redox-active compounds in mitochondria. Hence
the importance of developing mitochondrion-targeted redox-active
constructs, which has stimulated ground-breaking research aiming at
the delivery of ROS-abating compounds (reviews: [46–53]). Conjuga-
tion to membrane-permeant cations, the most widely used technique,
results in accumulation according to Nernst's law. We have recently
used conjugation to triphenylphosphonium to produce mitochon-
driotropic derivatives of quercetin [54], and resveratrol [55].
From the point of view of redox action polyphenols are ambivalent
compounds [56,57]. The same chemical properties that confer them
anti-oxidant character may lead, under different conditions, to a pro-
oxidant effect [58,59]. Some polyphenols, including ﬂavonols, inhibit
peroxidases [60,61], andmay alter the redox poise of cells by acting on
enzymes of this class, including the mitochondrial thioredoxin–
peroxiredoxin system andmitochondrial phospholipid hydroperoxide
glutathione peroxidase. They may thus hinder or enhance the
permeabilization of the IMM, a potentially useful outcome either way.
To gain clues as to how polyphenols might act on the MPTP, we
have studied the effects of some representativemembers of the family
on it, observing the activity of the pore at the single-channel level in
patch-clamp experiments. We have then used the induction of
swelling of isolated mitochondria to verify the effects of one of the
compounds most efﬁcacious in electrophysiological experiments,
quercetin, on suspensions of isolated organelles. The two experi-
mental approaches led to apparently contradictory results, under-
scoring the importance of carefully considering experimental
conditions when evaluating the biomedical effects of these potentially
extremely useful natural compounds.
2. Materials and methods
2.1. Materials
Daidzeinwas purchased from LKT Laboratories (St. Paul, MN, USA),
galanginwas from Indoﬁne (Hillsborough, NJ, USA). All other reagents
were from Sigma/Aldrich/Fluka/Riedel de Haen or from sources
speciﬁed in the text.2.2. Cells and mitochondria
Human Colon Tumor (HCT116) cells [62] (kindly provided by B.
Vogelstein) were grown in Dulbecco's Modiﬁed Eagle Medium
(DMEM) (GIBCO) plus 10 mM HEPES buffer, 10% (v/v) fetal calf
serum (Invitrogen), 100 U/ml penicillin G (Sigma), 0.1 mg/ml
streptomycin (Sigma), 2 mM glutamine (GIBCO) and 1% nonessential
amino acids (100× solution; GIBCO), in a humidiﬁed atmosphere of
5% CO2 at 37 °C. HCT116 mitochondria were isolated as described in
[63]. Rat liver mitochondria were prepared by standard differential
centrifugation procedures and obtained as a suspension in 0.25 M
sucrose and 5 mM Hepes/K+, pH 7.4.
2.3. Electrophysiology
Patch-clamp experiments on mitoplasts were carried out essen-
tially as described by [64]. A few μl of mitochondrial suspension were
added to 1 ml of standard electrophysiology medium (150 mM KCl,
0.5mMCaCl2,1 mMPi, 20mMHepes, pH 7.4) in the patch-clamp dish,
and allowed to settle for approximately 10 min. The dish was then
extensively perfusedwith the samemedium to remove the objects not
attached to the bottom. At variance from [64], mitoplasts were not
produced by osmotic shock, but by “spontaneous” swelling in the
presence of Ca2+ and Pi. Under these permeability transition-inducing
conditions the mitochondria swell producing objects with a diameter
of 1–3 μm on which seals were established under symmetrical ionic
conditions. Pipette resistance was 4.6±0.4 MΩ (N=49). Connection
to the Ag/AgCl ground electrode compartment was via a 1 M KCl agar
bridge. For inhibition, a few μl of concentrated inhibitor solution were
added, and the bath contents were thoroughly mixed by withdrawing
and re-adding aliquots with a Gilson pipette. Seal conﬁguration was
mitochondrion-attached, as conﬁrmed by the polarity of the voltage
dependence of the 107 pS channel [65]. Voltage was controlled by an
Axopatch 200 unit, and Axon pClamp software was used for voltage
control and data analysis. The voltages reported in this paper are those
applied to the patch-clamp pipette interior. Current (cations) ﬂowing
from the pipette to the ground electrode is considered as positive and
plotted upwards. The voltage was either controlled manually or
applied as trains of sequential square pulses to ±20 mV with
alternating polarity and a 0.1-second “rest” period at 0 mV between
pulses. All data were ﬁltered at 10 kHz and recorded on tape using a
VR-10B (Instrutech) adaptor, and recovered later for off-line analysis.
2.4. Mitochondrial swelling and respiration assays
Mitochondrial volume changes were followed as pseudo-absor-
bance decrease at 540 nm in a multi-sample Kontron Uvikon 922 UV/
Vis spectrophotometer. The experimentswere initiated by the dilution
of the mitochondrial suspension into 250 mM sucrose, 10 mM Hepes/
K+, 5 mM succinate/K+, 1.25 μM rotenone, and 1 mM Pi/K+, pH 7.4
(suspension buffer), supplemented with the desired concentration of
CaCl2 and/or inhibitors. The temperature was 20 °C. Swelling traces
shown in the same ﬁgure were recorded simultaneously. Respiration
was monitored as [O2] decrease in a stirred, closed, thermostatted
chamber containing a Clark electrode.
2.5. Fluorescence assays
The formation of ﬂuorescent, oxidized species from dihydroethi-
dine (HE) (Invitrogen/Molecular Probes) was used to monitor the
production of O2
U− in RLM suspensions [66]. Stock solutions were
prepared as detailed in [67] and used as described in [68]. RLM were
incubated at 0.5 mg prot ml−1 in suspension buffer in a stirred quartz
cuvette in a Shimadzu RL-5000 spectroﬂuorimeter for 2–4 min to
check for signal stability. Quercetin was then added, followed by HE.
Excitation was at 470 nm (3 nm slits) and emission was monitored at
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U− generation in cells was detected using the
mitochondriotropic probe MitoSOX Red® (Invitrogen/Molecular
Probes) used as speciﬁed by the producer. Cells were sown on
coverslips and cultured for three days. They were then placed in a
holder, incubated for 10 min with 1 μMMitoSOX Red in HBSS (in mM
units: NaCl 136.9, KCl 5.36, CaCl2 1.26, MgSO4 0.81, KH2PO4 0.44,
Na2HPO4 0.34, and glucose 5.55, pH 7.4 (with NaOH)), then washed
three times, covered with 1 ml HBSS, and placed on the microscope
stage. Additions were performed by withdrawing 0.5 ml of incubation
medium, adding the desired solute to this aliquot or to 0.5 ml of fresh
medium with identical composition, mixing, and adding back the
solution into the chamber at a peripheral point. Excitationwas at 500–
520 nm, and ﬂuorescence was collected at λN570 nm. Images were
automatically acquired at 1 min intervals using an Olympus
Biosystems apparatus comprising an Olympus IX71 microscope and
MT20 light source, and processedwith CellR© software. Images (Fig. 4)
are presented using the same display parameters; ﬂuorescence in-
tensities can thus be compared.Table 1
Effects of selected polyphenols on MPTP activity in patch-clamp experiments.
Structure Polyphenol
Myricetin
R1fH, R2,R3,R4,R5fOH
Quercetin
R1,R4fH, R2,R3,R5fOH
Morin
R2,R4fH, R1,R3,R5fOH
Kaempferol
R1,R2,R4fH, R3,R5fOH
Galangin
R1,R2,R3,R4fH, R5fOH
Catechin
R1,R4fH, R2,R3fOH
Epigallocatechin (EGC)
R4fH, R1,R2,R3fOH
Genistein
RfOH
Daidzein
RfH
Resveratrol
1,3,5-trihydroxybenzene
Dithiothreitol (DTT)
Di-t-butyl-p-hydroxytoluen
a In the 3 negative experiments [quercetin] was 10 μM in 2 cases, 45 μM in the third.3. Results
3.1. Inhibition of the MPTP by readily oxidizable polyphenols
The most straightforward approach to an assessment of the effects
of polyphenols on the MPTP is to observe the pore itself at the single-
channel level in patch-clamp experiments, recording what happens
when a polyphenol is added. We performed experiments of this type
with a series of polyphenols (Table 1), using mitochondria isolated
from rat liver (RLM) or from cultured HCT116 cells. Fig. 1 and
Supplementary Figs. 1–3 illustrate representative experiments.
In these experiments, a computer-driven routine applied trains of
100 1-second, 20 mV “square” voltage pulses of alternating sign,
separated by 100-ms “resting” zero-voltage intervals, to the mitoplast
membrane patch. This protocol is routinely used in our lab in order to
distinguish drug-induced from voltage-induced channel closure. A
channel may stochastically close during a pulse, but it will re-open
during the resting interval unless inhibited by the compound beingConcentration
range (μM)
N
Inhibition
50 3
Yes(2)/no(1)
5–50 27a
Yes(24)/no(3)
50 4
Yes(3)/no(1)
50 3
No
50 3
No
50 2
No
50 2
No
50–100 2
No
50 5
No
50 2
No
50 2
No
2000 2
No
e 200–500 5
Yes(4)/no(1)
Fig. 1. Inhibition of the MPT pore by quercetin in patch-clamp experiments. In this
representative experiment on an HCT116 mitoplast, 20-mV, 1-second voltage pulses of
alternating polarity were applied sequentially, with a 0.1-second interval at zero voltage
between pulses. Top panel: A column plot of the mean current ﬂowing in the circuit
during each 1-second pulse. Addition of 50 μMquercetin caused closure of the channels,
i.e., a decrease of the mean current. (A–D) Current records corresponding as indicated
to the plot segments identiﬁed by bars and letters in the top panel. Immediately after
the addition of quercetin the patch still exhibited a residual activity characterized by a
fast gating (“noisy” trace) which eventually disappeared leaving only the leak current
(D). Sampling: 1 kHz. Filter: 200 Hz.
Fig. 2. Ca2+ and quercetin act synergically to induce swelling of mitochondria in
suspension. Parallel light scattering experiments initiated by the addition of 1 mg
prot ml−1 RLM to the cuvettes. (A) Increasing concentrations of quercetin (Q), at
constant [Ca2+], result in increasing rate of propagation of swelling in the
mitochondrial suspension. The medium contained in all cases 40 μM CaCl2 plus:
trace 2: 25 μM Q; trace 3: 40 μM Q; trace 4: 50 μM Q. (B) Increasing concentrations of
Ca2+, at constant [quercetin], result in accelerated swelling. Cyclosporin A blocks
swelling. The medium contained: trace 1: 40 μM CaCl2; trace 2: 20 μM CaCl2+40 μM
Q; trace 3: 30 μM CaCl2+40 μM Q; trace 4: 40 μM CaCl2+40 μM Q; trace 5: 50 μM
CaCl2+40 μM Q; trace 6: 40 μM CaCl2+40 μM Q+1 μM Cyclosporin A. The traces
shown are representative of 6 (A) and 5 (B) analogous experiments.
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a glance by observing a graph plotting themean current ﬂowing in the
circuit during each 1-second voltage pulse vs. time (top panel in Fig.
1). Channel activity was monitored for a control period, after which
the desired compound was added. Since the experiments were
conducted in the mitoplast-attached conﬁguration, the effect, if any,
took place after a variable lag time, inversely related to the
concentration applied, needed for the diffusion from the bath to the
membrane patch enclosed by the pipette rim. Activity was therefore
generally monitored for at least two 100-pulse (110-second) trains
after the addition before pronouncing the addition to have been
ineffective.
The results are summarized in Table 1. For this tabulation, an
experiment was arbitrarily considered to have produced inhibition if
the open probability (calculated from the mean current, leak
subtracted) of the megachannels in the patch was eventually reduced
by at least 70%. According to this criterion, among the polyphenols
tested quercetin (Fig. 1), myricetin and morin (Supplementary Fig. 1)
were able to inhibit the MPTP in a majority of experiments. BHT, a
widely used reducing agent, radical scavenger and MPTP inhibitor
(e.g. [17] and Refs. therein) had an analogous effect (Supplementary
Fig. 2). Catechin and epigallocatechin, which have hydroxylic
substitution patterns in common with quercetin and myricetin, but
are less readily oxidized, did not inhibit the pore (Table 1).
The current records reveal an interesting detail. In most experi-
ments, the addition of an effective polyphenol initially caused only a
partial inhibition of channel activity. The residual activity was
characterized by a previously absent fast gating, which – especiallyif more than one active channel was present in the patch – generally
appeared as irregular “open channel noise”. This behaviour is clearly
visible in Fig. 1, and particularly in Supplementary Fig. 1, an example
chosen because morin induced a relatively slower and more regular
gating pattern. The amplitude of this “ﬂickering” generally decreased
in time and in most experiments (quercetin: 19/24; myricetin: 1/3;
morin: 1/3) a complete and permanent (i.e., lasting until the tight seal
collapsed, at least a fewminutes) disappearance of activity eventually
set in within the timeframe of the experiment.
3.2. Quercetin induces the permeability transition in mitochondrial
suspensions
While patch-clamp allows one to follow the behaviour of the
individual channels “in real time”, the most popular technique used to
study the mitochondrial permeability transition relies on MPT-
dependent colloidosmotic swelling of isolated mitochondria. We
therefore investigated the effects of quercetin, the most reliable
inhibitor in electrophysiological experiments, using that approach.
The addition of quercetin to mitochondria suspended in a standard
sucrose-based buffer containing phosphate and a respiratory sub-
strate but no added Ca2+ was without detectable effect (not shown).
MPT induction generally requires Ca2+, at concentrations depending
on conditions and on the individual mitochondrial preparation and its
“age”. We checked therefore whether quercetin would inhibit MPT
induction by Ca2+. This was not the case. On the contrary, at
concentrations N10 μM the polyphenol acted synergically to induce
swelling (Fig. 2), which could be inhibited by CsA (Fig. 2B), an acidic
(5.5) pH, ADP, Mg2+ and DTT, well known inhibitors of the MPT
(Supplementary Fig. 4 and not shown). Respiration was analogously
stimulated, and CsA inhibited this stimulation (not shown).
3.3. Quercetin induces production of O2
U−
Since ROS are MPT inducers, and polyphenols can function as pro-
oxidants, we checked whether the presence of quercetin was
associated with an increased formation of superoxide anion in our
Fig. 3. Quercetin enhances superoxide generation by suspensions of mitochondria. 50 μM
quercetin and 6.34 μM HE were added to the stirred suspension of RLM as indicated.
Consecutive (A→C) recordings using the same preparation of RLM. For trace B the
medium contained 10 μM bathophenanthroline and bathocuproine. For trace C (control),
no quercetinwas added. The traces shown are representative of 4 analogous experiments.
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sensitive to O2
U− [66–68], was indeed greatly enhanced by 50 μM
quercetin (compare traces A and C in Fig. 3). Note also that the extent
and kinetics of “ethidium” ﬂuorescence development are the sameFig. 4. Superoxide production in cells exposed to quercetin. A representative imaging experim
A computer-generated plot of the ﬂuorescence emitted by the ﬁeld areas (Regions Of Inter
ﬂuorescence of the ROIs “cells1” and “cells2” is due to the difference in the area covered. 50
analogous plot from two cell-ﬁlled ROIs in a control experiment inwhich quercetinwas not ad
10min, no addition. Quercetinwas added seconds after this imagewas acquired. (D) After 46
was taken. (E) After 40 min in the presence of 2 μg/ml Antimycin A.regardless of whether the suspension medium contained (trace B) or
not (trace A) speciﬁc iron and copper ion chelators (see below and
Discussion). These experiments are complicated by the occurrence of
the MPT: artefactual variations in the ﬂuorescence signal are
introduced by changes in light scattering due to swelling. To avoid
this complication, observations of O2
U− generation by the isolated RLM
were carried out in the presence of CsA.
A very slow ﬂuorescence increase took place in cultured HCT116
cells loaded with MitoSOX Red®, a hydroethidine derivative targeted
tomitochondria by a phosphonium ionmoiety [69,70], and exposed to
quercetin (Fig. 4). Although slow, this increase was reproducible, and
reproducibly absent in controls (N=5 and 3 respectively). As
expected, it was markedly enhanced by the mitochondrial electron
transport chain blocker Antimycin A, known as an inducer of
superoxide production (e.g. [69]). These observations suggest a mild
pro-oxidant effect of quercetin also within cells in culture.
3.4. MPT induction is due to Fe- and Cu-catalyzed ROS production
Superoxide anion is well known to be rapidly converted to H2O2 by
SOD. Hydrogen peroxide can in turn give rise to very reactive hydroxy
and peroxy radicals via metal-catalyzed Fenton-type reactions.
Whether O2
U− itself can act as an MPT inducer is unclear. A direct
measurement of H2O2 production under our conditions was made
difﬁcult by the fact that ﬂavonoids, including quercetin, inhibit the
peroxidases used in most H2O2 assays (not shown; e.g.: [60,61,71]). A
suspension of isolated mitochondria may be reasonably expected to
contain reactive Fe and Cu species. We assessed the role of these
metals by checking whether quercetin-enhanced swelling would be
antagonized by speciﬁc chelators. Indeed bathophenanthrolin (BF;ent with MitoSOX Red®-loaded HCT116 cells. See Materials and methods for details. (A)
est, ROI) identiﬁed in panel B. Images were acquired every 60 s. The difference in the
μM quercetin and 2 μg/ml Antimycin A were added when indicated. The inset shows an
ded. (B–E: Representative images taken from the sequence used. (B) At time 0. (C) After
min in the presence of 50 μMquercetin. Antimycin Awas added seconds after this image
Fig. 5. Induction of the permeability transition by quercetin is mediated by Fe and Cu ions. (A) Swelling. All traces: the medium contained 50 μM CaCl2. Further additions (from the
beginning): trace 2: 50 μMQ; trace 3: 50 μMQ+1 μMCSA; trace 4: 50 μMQ+10 μM BF and BC; trace 5: 50 μMQ+10 μM BF. (B) Respiration. When indicated, 50 μMQwas added in
both runs, 1 μM FCCP only in 2. The medium of trial 2 contained 10 μM BF and BC. The data are representative of 6 analogous experiments.
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bathocuproine (BC; 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;
log KCu: 19.1; log KFe: ∼0), speciﬁc chelators of iron and copper, with
negligible afﬁnity for Ca2+, strongly reduced swelling and the
attendant respiration increase (Fig. 5A, B). Deferoxamine and
penicillamine, two other iron and copper (respectively) chelating
agents, had similar effects (not shown). As expected, the presence of
added μM-range concentrations of Fe and Cu ions as well as of
quercetin produced a rapid, Ca2+-independent, CsA-insensitive
pseudo-adsorbance decrease (not shown).
4. Discussion
The results show that readily oxidizable polyphenols, quercetin in
particular, can both inhibit and activate the permeability transition
pore, in a clear demonstration of the ambivalent nature of these
redox-active compounds. Inhibition can be observed in patch-clamp
experiments, conducted under well-controlled conditions, in the
presence of very fewmitoplasts (in a typical experiment only perhaps
100 remain in the 1-ml chamber after washing) bathed in a medium
containing no transition metal ions. Activation is observed under
different circumstances: a dense (typically 1 mg prot ml−1) suspen-
sion of isolated organelles containing sequestrable iron and copper
species capable of catalyzing quercetin oxidation with the production
of O2
U−, H2O2 and other ROS which appear to be the proximal inducing
agents.
A priori, inhibition might be due to molecular interactions, i.e.,
phenomena not involving a chemical reaction, or to redox events.
What is known about the MPTP points to this latter hypothesis as the
more likely of the two. Electrochemical data on polyphenols are scarce
and vary depending on the experimental conditions used. None-
theless, available Ep/2 values [72–74] are sufﬁcient to indicate the
following ease-of-oxidation ranking: myricetin, quercetin, mor-
inNkaempferol, catechinNresveratrolNgalanginNgenistein, daidzein.
These data correlate well with those in Table 1, and are thus consistent
with a redox mechanism for MPT inhibition. Compounds with
structure and functional groups similar to those of quercetin, e.g.
kaempferol or catechin, but less readily oxidizable, do not readily
inhibit the channel, whereas BHT, in which the bulky t-butyl groups
presumably impede strong interactions of the lone hydroxyl group
with proteins, does.
The fast gating induced in a ﬁrst phase of the inhibition process
may thus be associated with redox events, i.e., it may reﬂect the
electron transfers and conformational changes involved in the
transition between (the) oxidized specie(s) constituting the open
state of the MPTP and the reduced and closed channel, and vice versa.
These redox events are believed to be reversible thiol/disulﬁdeinterconversions (see Introduction). The current variations thus may
represent a record of the forward and backward steps of a chemical
reaction: reduction of a disulﬁde group would cause channel closure,
its re-oxidation would precipitate opening. The frequency of these
events would be expected to be a function of the concentration of the
reagent at the site of action – which in turn depends on the geometry
of the pipette/membrane system and on the time elapsed since the
addition – and of its propensity to cede electrons. In some cases, such
as the one in Supplementary Fig. 1, this would be low enough for the
events to be well resolved. Alternatively, a reduction may alter the
structure of the channel, destabilising both the open and the closed
states (fast gating). In any case, a further, subsequent redox event would
then block the protein in the closed-channel state (prolonged closure),
explaining the eventual complete disappearance of any activity. The
observed behaviour may thus be easily reconciled with the presence of
multiple dithiol groups exerting control of MPTP activity [32–35].
It is relevant that in patch-clamp experiments quercetin nearly
always induced channel inhibition. This implies that all the individual
channels observed contained oxidized groups whose reduction
caused channel disappearance, and thus that MPTP channel genesis
always (or at least in the vast majority of cases) involves oxidation,
presumably of thiols. Note that in the experiments reported here the
mitochondria had beenmade to swell by incubation for a fewminutes,
in the patch-clamp dish, with Ca2+ and Pi, i.e., under classical MPT-
inducing conditions, without any added oxidizing agents.
Presumably MPTP-inhibiting reduction of disulﬁde groups by
quercetin also takes place in suspension experiments. This does not
result in any detectable inhibition of the propagation of swelling in the
population. This lack of effect is not surprising, since any anti-oxidant
action is presumably overwhelmed by the generation of ROS.
Furthermore, for the disulﬁde moieties to be reduced, they must
ﬁrst of all form via oxidation of thiols. Their formation is thought to
coincide with PTP opening, which leads to complete swelling in a
matter of hundreds of milliseconds [22]. It is also possible that the
relevant reaction may be thiol arylation by products arising from
oxidation of the quercetin catechol moiety, as proposed in the case of
mangiferin, another polyphenol that can induce the MPT [75].
Subsequent closure of the pore is not expected to lead, except under
speciﬁc experimental conditions [76] to shrinkage. Furthermore, more
than one MPTP may be open in any given mitochondrion at any given
time, and there is no reason to expect individual pores to synchronize
their opening or closing. Just one open pore would be sufﬁcient to
induce swelling of its mitochondrion.
The protective effect of Fe/Cu chelation (Fig. 5) implies that
“secondary”, Fenton reaction-derived ROS, rather than O2
U− itself, are
mostly involved in the activation of the MPTP. This conclusion is based
on the observation that BF and BC drastically slow down the
1431U. De Marchi et al. / Biochimica et Biophysica Acta 1787 (2009) 1425–1432propagation of swelling but have little or no effect on the O2
U−
mediated formation of ﬂuorescent HE-derived species in RLM
suspensions (compare traces A and B in Fig. 3). Quercetin-promoted
ROS production in cells (Fig. 4), although minor in comparison with a
strong stimulus such as Antimycin, may well account at least in part
for the antiproliferative/cytotoxic activity exhibited by readily
oxidizable polyphenols at high concentrations [57,73,77,78].
Given that in vitro reactive polyphenols can act as either agonists
or antagonists of the MPT depending on conditions as well as on their
properties, it is difﬁcult to predict how they would act in vivo [57].
Whether a ﬂavonoid has a protective or cytotoxic action may well
depend on its concentration [79]. This ambivalence is exempliﬁed by
the recent report that “mitoQ” [64], developed as an anti-oxidant
agent, can also act as a pro-oxidant [80]. In electrophysiological
experiments quercetin often succeeded in inhibiting the MPTP at low
μM levels (see Supplementary Fig. 3). MPT-inducing effects have been
observed only at higher (N10 μM) concentrations, in the presence of
Ca2+, and with dense suspensions of mitochondria. These conditions
are not likely to occur in vivo upon consumption of quercetin-
containing foods, since the bioavailability of polyphenols in foodstuffs
is low and metabolism by enterocytes and hepatocytes is very
effective [81–83]. On the other hand, other modes of administration
may be envisioned in a therapeutic perspective, and pro-drugs are
beginning to be considered as a strategy to enhance adsorption and to
increase the levels of active species where needed (e.g.: [84]).
Mitochondrial targeting by linkage of a triphenylphosphoniummoiety
is intended precisely to increase the concentration of the compound in
mitochondria.
A variety of cancers endure oxidative stress and elevated levels of
copper ions [85]. Our results suggest that these conditions may make
them vulnerable to polyphenol-induced, MPT-mediated cell death if
sufﬁcient levels of oxidizable molecules are delivered. An anti-oxidant
overall effect may also have oncological applications [5,7]. The results
reported in this paper thus support a polyphenol-based approach to
mitochondrial medicine, and stress the need for observations at the
level of cellular and animal experimental systems.
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ANT: adenine nucleotide translocator
BC: bathocuproine
BF: bathophenanthroline
BHT: 2,5-di-t-butyl-p-hydroxytoluene
CL: cardiolipin
CsA: cyclosporine A
FCCP: carbonyl cyanide p-triﬂuorometoxyphenyl hydrazone
HIF: hypoxia-inducible transcription factor
IMM: inner mitochondrial membrane
HE: dihydroethidine
HBSS: Hank's balanced salt solution
I/R: ischemia/reperfusio
MPTP:mitochondrial permeability transition pore
PiC: phosphate carrier
RLM: rat liver mitochondria
ROI: region of interest
ROS: reactive oxygen species
SOD: superoxide dismutase
VDAC: voltage-dependent anion channel (mitochondrial porin)
